We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

Back to rankings

53 hedge funds and large institutions have $35M invested in Biostage, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

12% more capital invested

Capital invested by funds: $31.1M → $35M (+$3.87M)

4% more funds holding

Funds holding: 51 → 53 (+2)

50% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 20

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
10
Reduced
20
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
+$669K
2
Morgan Stanley
Morgan Stanley
New York
+$594K
3
ARC
Absolute Return Capital
Massachusetts
+$412K
4
6CM
683 Capital Management
New York
+$373K
5
SCM
Signia Capital Management
Washington
+$373K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$1.4M
2
PM
Penbrook Management
New York
-$1.19M
3
State Street
State Street
Massachusetts
-$762K
4
Charles Schwab
Charles Schwab
California
-$337K
5
TCIM
TIAA CREF Investment Management
New York
-$266K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$3.88M -$38K -4,465 -1%
GIM
2
Granahan Investment Management
Massachusetts
$3.77M -$170K -20,000 -5%
BIT
3
BlackRock Institutional Trust
California
$3.43M -$184K -21,623 -6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.67M -$49.7K -5,831 -2%
PAIM
5
Punch & Associates Investment Management
Minnesota
$2.48M – – –
HSA
6
Hussman Strategic Advisors
Maryland
$2.43M – – –
RA
7
Royce & Associates
New York
$1.8M -$168K -19,700 -10%
Morgan Stanley
8
Morgan Stanley
New York
$1.77M +$594K +69,706 +70%
6CM
9
683 Capital Management
New York
$1.5M +$373K +43,837 +44%
PM
10
Penbrook Management
New York
$1.46M -$1.19M -139,819 -50%
BA
11
BlackRock Advisors
Delaware
$1.19M -$34.6K -4,066 -3%
GC
12
Guggenheim Capital
Illinois
$821K +$669K +78,596 New
Northern Trust
13
Northern Trust
Illinois
$764K -$89.6K -10,521 -13%
SCM
14
Signia Capital Management
Washington
$700K +$373K +43,796 +189%
USAA
15
United Services Automobile Association
Texas
$589K – – –
BCM
16
Bridgeway Capital Management
Texas
$525K – – –
ARC
17
Absolute Return Capital
Massachusetts
$506K +$412K +48,394 New
PAM
18
Panagora Asset Management
Massachusetts
$388K +$124K +14,531 +64%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$364K – – –
Deutsche Bank
20
Deutsche Bank
Germany
$341K +$256K +30,048 +1,124%
SM
21
Sabby Management
Florida
$290K +$236K +27,730 New
Bank of America
22
Bank of America
North Carolina
$290K +$236K +27,745 +924,833%
PP
23
Paloma Partners
Connecticut
$287K +$234K +27,454 New
PPA
24
Parametric Portfolio Associates
Washington
$266K +$25K +2,934 +13%
TC
25
TFS Capital
Pennsylvania
$244K +$494 +58 +0.2%
1
2 3

BSTG Hedge Fund Activity: Q2 2014 in Review

53 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q2 2014, worth a combined $35M — up 12% from $31.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BSTG positions and 11 closed out — a net gain of 2 holders — while 10 added to existing stakes and 20 trimmed.

The largest buyer was Guggenheim Capital, opening a new position worth an estimated $669K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.4M.

  • 53 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q2 2014, up from 51 in Q1 2014.
  • Funds reported $35M of Biostage, Inc. Common Stock stock for Q2 2014, up 12% quarter-over-quarter.
  • 13 funds opened new Biostage, Inc. Common Stock positions in Q2 2014 and 11 closed out, a net change of +2 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q2 2014 was Guggenheim Capital, an estimated $669K added.
  • The largest Biostage, Inc. Common Stock seller in Q2 2014 was BlackRock Fund Advisors, an estimated $1.4M sold.

Based on aggregated 13F filings for Q2 2014.